IT8748117A0 - Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche - Google Patents

Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche

Info

Publication number
IT8748117A0
IT8748117A0 IT8748117A IT4811787A IT8748117A0 IT 8748117 A0 IT8748117 A0 IT 8748117A0 IT 8748117 A IT8748117 A IT 8748117A IT 4811787 A IT4811787 A IT 4811787A IT 8748117 A0 IT8748117 A0 IT 8748117A0
Authority
IT
Italy
Prior art keywords
preventive
therapeutic agents
diabetic complications
glycine derivatives
glycine
Prior art date
Application number
IT8748117A
Other languages
English (en)
Other versions
IT1206823B (it
Inventor
Murase Masao
Maruo Shigeaki
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of IT8748117A0 publication Critical patent/IT8748117A0/it
Application granted granted Critical
Publication of IT1206823B publication Critical patent/IT1206823B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT8748117A 1986-06-27 1987-06-26 Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche IT1206823B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15214986 1986-06-27

Publications (2)

Publication Number Publication Date
IT8748117A0 true IT8748117A0 (it) 1987-06-26
IT1206823B IT1206823B (it) 1989-05-03

Family

ID=15534103

Family Applications (2)

Application Number Title Priority Date Filing Date
IT8748117A IT1206823B (it) 1986-06-27 1987-06-26 Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche
IT8748116A IT1206822B (it) 1986-06-27 1987-06-26 Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche

Family Applications After (1)

Application Number Title Priority Date Filing Date
IT8748116A IT1206822B (it) 1986-06-27 1987-06-26 Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche

Country Status (6)

Country Link
US (2) US4785018A (it)
JP (2) JPS63119455A (it)
DE (2) DE3721222A1 (it)
FR (2) FR2600646B1 (it)
GB (2) GB2193210B (it)
IT (2) IT1206823B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196849B (it) * 1986-12-16 1988-11-25 Rotta Research Lab Nuovi derivati degli acidi 5 pentilammino 5 oxo pentaoico e 4 pentilammino 4 oxo butanoico ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
US4962224A (en) * 1987-12-23 1990-10-09 American Home Products Corporation N-naphthoylglycines as aldose reductase inhibitors
CA1307537C (en) * 1987-12-23 1992-09-15 Jay E. Wrobel N-naphthoylglycines as aldose reductase inhibitors
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
ES2236757T3 (es) * 1995-11-24 2005-07-16 Glaxosmithkline S.P.A. Derivados de quinolina.
JP4444375B2 (ja) * 1997-03-14 2010-03-31 スミスクライン・ビーチャム・コーポレイション 新規キノリン−およびナフタレンカルボキサミド、医薬組成物およびカルパインの阻害方法
WO2002098421A1 (en) * 2001-06-05 2002-12-12 University Of Maryland, Baltimore Novel treatment for neurological and psychiatric disorders
WO2006034512A2 (en) * 2004-09-23 2006-03-30 Bayer Pharmaceuticals Corporation Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928610A (en) * 1970-06-06 1975-12-23 Hoechst Ag Benzene sulfonyl-urea preparation for treatment of diabetes mellitus and a method for treatment
US3939269A (en) * 1971-04-26 1976-02-17 Hoechst Aktiengesellschaft Benzenesulfon YL-semicarbazides for lowering blood sugar levels
JPS5216367A (en) * 1975-07-21 1977-02-07 Rikagaku Kenkyusho Plant growth control agent
US4195984A (en) * 1979-03-12 1980-04-01 Abbott Laboratories Herbicides derived from dihalo isonicotinoyl derivatives of amino acids
CA1182472A (en) * 1981-03-02 1985-02-12 Kazimir Sestanj N-[(2-naphthalenyl)thioxomethyl]glycine derivatives
CA1176269A (en) * 1981-03-02 1984-10-16 Kazimir Sestanj N-naphthoylglycine derivatives
AU544067B2 (en) * 1981-03-02 1985-05-16 Wyeth-Ayerst Canada Inc. Thioamides and amides. treatment of diabetes
US4337265A (en) * 1981-08-21 1982-06-29 Ayerst, Mckenna & Harrison Inc. Cyclohepta[b]pyrrole derivatives
US4604406A (en) * 1984-11-16 1986-08-05 Ayerst, Mckenna & Harrison, Inc. N-[6-methoxy-5-(perfluoroalkyl)-1-naphtholyl]-N-methylglycines and their thionaphthoyl analogs

Also Published As

Publication number Publication date
IT1206823B (it) 1989-05-03
DE3721223A1 (de) 1988-01-14
FR2600646B1 (fr) 1990-01-26
FR2600646A1 (fr) 1987-12-31
FR2600647A1 (fr) 1987-12-31
US4785018A (en) 1988-11-15
GB2192002B (en) 1990-04-11
GB2193210A (en) 1988-02-03
JPS63119455A (ja) 1988-05-24
GB2192002A (en) 1987-12-31
GB2193210B (en) 1990-03-28
JPS6399057A (ja) 1988-04-30
US4970214A (en) 1990-11-13
FR2600647B1 (fr) 1991-10-18
GB8715056D0 (en) 1987-08-05
IT8748116A0 (it) 1987-06-26
GB8715055D0 (en) 1987-08-05
IT1206822B (it) 1989-05-03
DE3721223C2 (it) 1991-11-14
DE3721222A1 (de) 1988-01-14

Similar Documents

Publication Publication Date Title
BR8603566A (pt) Composicao para o tratamento de tecidos
IT8522574A0 (it) Composizione farmaceutica eprocedimento per trattare il corpo umano con essa.
GB8804164D0 (en) Bandage for administering physiologically active compound
EP0259440A4 (en) METHOD FOR STIMULATING MELANOCYTES BY LOCALLY APPLYING ALPHA-MSH ANALOGS, AND COMPOSITIONS.
PT91096A (pt) Composicao de enxerto de tecido
GR3002659T3 (en) Pharmaceutical composition for treating inflammation in the eye
DK90089D0 (da) Hudbehandlingspraeparat
ZA898201B (en) Gestodene-containing agent for transdermal administration
ZA874251B (en) Therapeutic agent for skin ulcers
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
DK0416678T3 (da) Topiske præparater indeholdende Defibrotid
AU4530989A (en) Pharmaceutical composition for the treatment of cerebral edema
IT8748117A0 (it) Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche
GB2198942B (en) Therapeutic composition for diabetic complications
BR8905985A (pt) Composicao liquida aquosa para tratamento de tecidos
GB2183156B (en) Composition for treating skin disease
BG49522A1 (en) Pharmaceutist composition accelarating the healing of mounds
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
GB8804531D0 (en) Skin treatment formulations
AU3510489A (en) Pharmaceutical composition for treating tumor
GB8804420D0 (en) Skin treatment composition
GB8819737D0 (en) Skin treatment composition
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours
BR8902395A (pt) Composicao curavel e artigo

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19930419